The Regional Biocontainment Laboratory (RBL) at the Tulane National Primate Research Center stands at the forefront of critical infectious disease research. As one of the select NIAID-supported Biocontainment Laboratories, its work focuses on two vital missions: developing cutting-edge treatments, vaccines, and diagnostics for naturally occurring emerging infectious diseases, while also advancing countermeasures against potential bioterrorism agents.

The Tufts New England Regional Biosafety Laboratory (RBL) is one of the NIAID-supported Regional Biocontainment Laboratories. The RBL is available to researchers in industry, academia, government and not-for-profit, dedicated to the study of existing and emerging infectious diseases.

The Rutgers University Regional Biocontainment Laboratory is one of the NIAID-supported Biocontainment Laboratories. The RBL is a highly secure facility designed to provide an ultra-safe work environment for scientists and support staff, as well as the public at large.

The Colorado State University Regional Biocontainment Laboratory is one of the NIAID-supported Regional Biocontainment Laboratories. The Center provides a safe, secure, state of art facility for research, service, and training in pathogens that cause human and animal diseases.

As one of two National Biocontainment Laboratories constructed under grants awarded by the National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH), the Galveston National Laboratory (GNL) enables progress in our understanding of the fundamental mechanisms underlying the spread of infectious diseases and the pathogenesis of the diseases they cause.

The National Emerging Infectious Diseases Laboratories (NEIDL) is one of two National Biocontainment Laboratories constructed under a grant from the National Institute of Allergy and Infectious Diseases. The mission of the NEIDL is to generate and translate fundamental knowledge on high priority emerging infectious diseases for the benefit of the public health, locally, nationally and globally.

George Mason University's Biomedical Research Laboratory (BRL) is one of the NIAID supported Regional Biocontainment Laboratories. It operates as a central core facility in the Institute for Biohealth Innovation to advance research and develop novel diagnostics, therapeutics, and vaccines against viral and bacterial infectious agents by a diverse population of investigators.